Literature DB >> 9028365

Erectile functioning of men treated for prostate carcinoma.

J W Robinson1, M S Dufour, T S Fung.   

Abstract

BACKGROUND: Published reports of complication rates, such as erectile dysfunction, associated with treatments for prostate carcinoma are often used to guide patient decision-making and develop clinical guidelines. Unfortunately, the published data are largely comprised of case series from single institutions. Meta-analysis is a methodology for combining findings from several studies to produce a better result.
METHODS: A comprehensive literature review and subsequent meta-analysis of the rates of erectile dysfunction associated with external beam radiotherapy and radical prostatectomy was conducted. A simple logistic regression model was used to combine the data from 40 articles that met selection criteria.
RESULTS: The probability of maintaining erectile functioning after radiotherapy is 0.69. The probability after surgery is 0.42. This difference is significant. Analysis of the effects of variables such as patient age and stage of disease on erectile functioning could not be performed due to inconsistencies across studies and the limited number of studies reporting such variables.
CONCLUSIONS: The published data indicate that men with normal erectile functioning are more likely to retain this function after radiotherapy than after surgery. Attention is drawn to the weaknesses in the reviewed studies in the hope that the clinical trials of emerging treatments, such as cryotherapy, brachytherapy, three-dimensional conformal radiotherapy, and neoadjuvant hormones can be strengthened to reflect more accurately the rate of treatment-associated erectile dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9028365     DOI: 10.1002/(sici)1097-0142(19970201)79:3<538::aid-cncr16>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  [Erectile function after treatment of prostatic carcinoma].

Authors:  H Lindner
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

2.  Prostate cancer: 8. Urinary incontinence and erectile dysfunction.

Authors:  M M Hassouna; J P Heaton
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

3.  Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience.

Authors:  L J Korb; M K Brawer
Journal:  Rev Urol       Date:  2001

4.  Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions.

Authors:  Stephen J Lepore; Vicki S Helgeson; David T Eton; Richard Schulz
Journal:  Health Psychol       Date:  2003-09       Impact factor: 4.267

Review 5.  Prostate cancer, Incidence, management and outcomes.

Authors:  E J Small
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

6.  Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event.

Authors:  Fiona C Warren; Keith R Abrams; Su Golder; Alex J Sutton
Journal:  BMC Med Res Methodol       Date:  2012-05-03       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.